For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Guiding use of cannabis-based medicines for persistent pain
+Practice
In print
Clinical update
Guiding use of cannabis-based medicines for persistent pain
Wednesday 11 December 2024, 12:25 AM

Most patients tolerate cannabis-based medicines well; side effects are usually dose dependent [Image: Supplied]
This article discusses the use of cannabis-based medicines for hard-to-treat chronic pain, then introduces a new eLearning course on the rational use of these medicines
This Practice article has been endorsed by the RNZCGP and has been approved for up to 0.5 credits for continuing professional development purposes (2 , Educate small, BACK panel - grey
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.